[{"id":"bce15ec9-0e44-49bd-a75f-798ef9ef67f3","acronym":"","url":"https://clinicaltrials.gov/study/NCT03208959","created_at":"2021-01-18T15:49:33.902Z","updated_at":"2024-07-02T16:36:07.078Z","phase":"Phase 1","brief_title":"A Trial of HTI-1090 in Subjects With Advanced Solid Tumors","source_id_and_acronym":"NCT03208959","lead_sponsor":"Atridia Pty Ltd.","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HTI-1090"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 08/30/2017","start_date":" 08/30/2017","primary_txt":" Primary completion: 11/01/2018","primary_completion_date":" 11/01/2018","study_txt":" Completion: 01/23/2019","study_completion_date":" 01/23/2019","last_update_posted":"2022-07-20"}]